Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodeling
2018 · Nature Communications · 85 citations
https://doi.org/10.1038/s41467-018-03476-6
P
Pedro C. Silberman
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
13
Papers
1.3K
Citations
5
h-index
5
i10-index
Pedro C. Silberman is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Chromatin Remodeling and Cancer & CAR-T cell therapy research. The author has an h-index of 5, co-authored 12 publications.
ORCID: 0000-0002-1735-4679Papers by this author
worksResearch topics
topicsChat about Author
Papers
Chat
Click to start Chat